In this issue:
Adalimumab originator vs biosimilars for psoriasis
Long-term outcomes after new-onset psoriasis
Drug survival of apremilast in psoriasis
COVID-19 hospitalisation and mortality in patients with psoriasis
Impact of COVID-19 on psoriasis patients
Calcipotriol/betamethasone dipropionate foam for plaque psoriasis
Biologics and the gut microbiome in psoriatic patients
Psoriasis in the geriatric population
Dermoscopic features of nail psoriasis
Review of therapies and recommendations for scalp psoriasis
Please login below to download this issue (PDF)